Global healthcare private equity (PE) deal value reached a record $191 billion in 2025, surpassing the previous peak in 2021, according to a Bain & Company report. This surge was driven by a significant increase in deals over $1 billion and a rebound in exit values. India led the Asia-Pacific region in PE deal volume for 2024, accounting for 26% as buyout activity shifted from China. The biopharma and provider segments remain key drivers, with growth also seen in MedTech and healthcare IT.